Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019
11 oct. 2019 10h58 HE
|
FibroGen, Inc
SAN FRANCISCO, Oct. 11, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced that results from the global Phase 3 roxadustat clinical program will be presented at the American...
FibroGen Congratulates Dr. William G. Kaelin, Jr., Scientific Advisory Board Member, on Receipt of the 2019 Nobel Prize in Physiology or Medicine
07 oct. 2019 17h57 HE
|
FibroGen, Inc
SAN FRANCISCO, Oct. 07, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) is pleased to announce that William G. Kaelin, Jr., who serves on the company’s Scientific Advisory Board, has been...
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment of Anemia in Cancer Patients Receiving Chemotherapy
26 sept. 2019 07h00 HE
|
FibroGen, Inc
SAN FRANCISCO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced first patient dosed in the company’s Phase 2 clinical study of roxadustat, a first-in-class...
The New England Journal of Medicine (NEJM) Publishes Roxadustat China Phase 3 Results for the Treatment of Anemia in Chronic Kidney Disease Patients Receiving Dialysis
24 juil. 2019 18h53 HE
|
FibroGen, Inc
-- One of Two Concurrent Publications of Roxadustat China Phase 3 Results in The New England Journal of Medicine -- SAN FRANCISCO, July 24, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN)...
Europe Blood and Blood Components Market to hit $5 billion by 2024: Global Market Insights, Inc.
19 juin 2019 01h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, June 19, 2019 (GLOBE NEWSWIRE) -- Russia blood and blood components market is estimated to witness fastest growth to reach USD 840 million by 2024. Growing geriatric...
Trivedi Global, Inc. Announces Research by Alice Branton on Energy Treated Iron to Potentially Provide a Formulation Which Provides a Better Therapeutic Response to Anemia.
19 avr. 2019 10h00 HE
|
Trivedi Global, Inc.
Las Vegas, NV, April 19, 2019 (GLOBE NEWSWIRE) -- Alice Branton, an evidence-based healer, today released research results on the beneficial impact of biofield energy treatment on improving...
New American Kidney Fund Survey Highlights Importance of Patient-Practitioner Discussions About Anemia
04 févr. 2019 12h29 HE
|
American Kidney Fund
Rockville, MD, Feb. 04, 2019 (GLOBE NEWSWIRE) -- A new survey by the American Kidney Fund (AKF) shows gaps in patient awareness and understanding of anemia, a serious health condition that is a...
Blood and Blood Components Market worth over $43.5 Billion by 2024: Global Market Insights, Inc.
07 janv. 2019 05h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Jan. 07, 2019 (GLOBE NEWSWIRE) -- U.S. blood and blood components market dominated the global industry with more than 35% market share in 2017. Rising number of surgeries...
FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat for Treatment of Anemia in Patients with Chronic Kidney Disease
20 déc. 2018 07h00 HE
|
FibroGen, Inc
SAN FRANCISCO, Dec. 20, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today...
FibroGen Reports Third Quarter 2018 Financial Results
08 nov. 2018 16h02 HE
|
FibroGen, Inc
—Roxadustat New Drug Applications under Review in China and Japan——Phase 3 Clinical Trials in IPF and Pancreatic Cancer to Initiate in First Quarter 2019——Conference Call Today at 5:00 p.m. Eastern...